[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Rehman Medical Institute - RMI\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":168},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,45,72,91,116,136,153],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100596083","phase-4-comparison-of-omeprazole-vs-vonoprazon-in-treatment-of-h-pylori-infection-100596083",false,"NCT07040839","Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection","Comparative Efficacy of Omeprazole and Vonoprazan in the Treatment of Helicobacter Pylori Infection","Inclusion Criteria:\n\n* All patients who tested positive on stool antigen\n\nExclusion Criteria:\n\n* patients under 12 years old.\n* Patients who have penicillin allergy.\n* Patients who have underlying dysrhythmia forbidding the use of macrolide -. Patient who have hypersensitivity to any of these antibiotics or proton pump inhibitors.",true,"ALL","12 Years",{"count":20,"type":21},128,"ESTIMATED","INTERVENTIONAL",[24],"PHASE4","Current studies have primarily focused on comparing the advantages and disadvantages of P-CAB and PPI drugs, with little comparison between different P-CAB drugs or between regimens with varying drug combinations and treatment durations.\n\nThis study aims to evaluate the clinical effectiveness of vonoprazan-based H. pylori eradication therapy and compare it to that of conventional PPI based therapy in clinical practice.",[27],"H Pylori",[29,30,31],"omeprazole","vonoprazon","proton pump inhibitors","NOT_YET_RECRUITING","2025-06-26",{"date":35,"type":36},"2025-06-27","ACTUAL",{"date":38,"type":21},"2025-07",{"date":40,"type":21},"2026-02",{"name":42,"class":43},"Rehman Medical Institute - RMI","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":16,"sex":17,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":22,"phases":56,"briefSummary":58,"conditions":59,"keywords":62,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":4},"100594288","determination-of-glycemic-index-and-glycemic-load-of-selected-melon-varieties-in-healthy-adults-100594288","NCT07017491","Determination of Glycemic Index and Glycemic Load of Selected Melon Varieties in Healthy Adults","A Randomized, Open-Label, Cross-Over Study to Determine the Glycemic Index and Glycemic Load of Selected Melon Varieties in Healthy Adults","Inclusion Criteria:\n\n1\\) Healthy males and females aged 18-50 years. 2) Body mass index (BMI) :Normal BMI (18-24.9) 3) Willingness to follow dietary instructions and attend all testing sessions\n\n* Exclusion Criteria:\n\n  1. Individuals with known metabolic disorders (e.g., diabetes, metabolic syndrome).\n  2. Use of medications or supplements affecting blood glucose.\n  3. Allergy or intolerance to melon or glucose solutions.\n  4. Not able to co ordinate","18 Years","50 Years",{"count":55,"type":21},16,[57],"NA","This crossover study aims to determine and compare the glycemic index (GI) and glycemic load (GL) of different melon varieties in healthy adults. Using glucose as the reference food, participants will consume test portions of each melon variety containing equivalent amounts of available carbohydrates.",[60,61],"Glycemic Index","Glycemic Load",[63],"GLYCEMIC LOAD","2025-06-11",{"date":66,"type":36},"2025-06-12",{"date":68,"type":21},"2025-06",{"date":70,"type":21},"2025-09",{"name":42,"class":43},{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":4,"eligibilityCriteria":78,"healthyVolunteers":16,"sex":17,"minAge":52,"maxAge":79,"enrollmentInfo":80,"targetDuration":4,"studyType":22,"phases":82,"briefSummary":83,"conditions":84,"keywords":85,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":87,"startDateStruct":88,"completionDateStruct":89,"leadSponsor":90,"locationsCount":4},"100594286","determination-of-the-glycemic-index-gi-and-glycemic-load-gl-of-watermelon-citrullus-lanatus-in-healthy-adults-100594286","NCT07017465","Determination of the Glycemic Index (GI) and Glycemic Load (GL) of Watermelon (Citrullus Lanatus) in Healthy Adults","Determination of the Glycemic Index (GI) and Glycemic Load (GL) of Watermelon (Citrullus Lanatus) in Healthy Adults (A Controlled Clinical Trial)","Inclusion Criteria:•\n\n1. Healthy adults (BMI 18.5-24.9kg\u002Fm2.\n2. No history of diabetes or metabolic disorders.\n3. Not taking any medication affecting glucose metabolism.\n\nExclusion Criteria:\n\n1\\) GI Disorders. 2) Recent infections or illness affecting glucose tolerance. 3) Non willing participants.\n\n\\-","30 Years",{"count":81,"type":21},30,[57],"This study aims to evaluate and compare the glycemic load (GL) and glycemic index (GI) of different types of watermelons commonly available in the market. Using glucose as the reference standard, the study will measure the blood glucose response following consumption of each watermelon type in healthy adult participants.",[60,61],[86],"GLYCEMIC INDEX",{"date":66,"type":36},{"date":68,"type":21},{"date":70,"type":21},{"name":42,"class":43},{"id":92,"slug":93,"hasResults":11,"nctId":94,"briefTitle":95,"officialTitle":96,"acronym":4,"eligibilityCriteria":97,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":98,"enrollmentInfo":99,"targetDuration":4,"studyType":22,"phases":101,"briefSummary":102,"conditions":103,"keywords":105,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":109,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":4},"100594613","phase-4-comparison-of-two-treatment-regimens-of-helicobacter-pylori-infection-100594613","NCT07021729","Comparison of Two Treatment Regimens of Helicobacter Pylori Infection","Comparison of Conventional Clarithromycin Vs Alternative Levofloxacin Based Regimen in Treatment of Helicobacter Pylori Infection","Inclusion Criteria:\n\n* All patients who tested positive on stool antigen will be included.\n\nExclusion Criteria:\n\n* patients under 12 years old. Patients who have penicillin allergy.\n* Patients who have underlying dysrhythmia forbidding the use of macrolide.\n* Patient who have hypersensitivity to any of these antibiotics.","90 Years",{"count":100,"type":21},156,[24],"The goal of this interventional study is to compare the efficacy of clarithromycin Vs levofloxacin based regimen in treatment of Helicobacter pylori infection in patients presenting to medical OPD who are tested positive for H pylori infection.. The main question\\[s\\] it aims to answer are:\n\n• Which regimen is superior in terms of efficacy Participants will be treated for H pylori Infection in with two different regimen If there is a comparison group: Researchers will compare two groups Group 1 will receive clarithromycin based regimen group 2 will receive levofloxacin based regimen to see the treatment response.",[104],"Helicobacter Pylori Infection",[106,107,108],"clarithromycin","levofloxacin","helicobacter pylori",{"date":110,"type":36},"2025-06-15",{"date":112,"type":21},"2025-12",{"date":114,"type":21},"2026-06",{"name":42,"class":43},{"id":117,"slug":118,"hasResults":11,"nctId":119,"briefTitle":120,"officialTitle":120,"acronym":4,"eligibilityCriteria":121,"healthyVolunteers":16,"sex":17,"minAge":52,"maxAge":79,"enrollmentInfo":122,"targetDuration":4,"studyType":22,"phases":123,"briefSummary":124,"conditions":125,"keywords":127,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":131,"lastUpdatePostDateStruct":132,"startDateStruct":133,"completionDateStruct":134,"leadSponsor":135,"locationsCount":4},"100594160","effect-of-locally-produced-mango-variety-on-glycemic-index-100594160","NCT07015827","Effect of Locally Produced Mango Variety on Glycemic Index","Inclusion Criteria:\n\n* Healthy non-diabetic adults\n* Normal fasting blood glucose levels\n* Willingness to provide informed consent\n\nExclusion Criteria:\n\nDiagnosis of diabetes mellitus or impaired glucose tolerance\n\n* Gastrointestinal, metabolic, or endocrine disorders\n* Current use of medications affecting blood glucose\n* Pregnant or lactating women\n* Smoking or alcohol consumption",{"count":81,"type":21},[57],"This randomized trial aims to assess the glycemic index (GI) of locally available mango varieties in healthy adult participants, using glucose as the reference food. The study will evaluate the postprandial blood glucose response elicited by selected mango varieties and compare it to the response produced by a standard glucose . The objective is to determine whether certain mango varieties have a lower glycemic impact, which may be relevant for dietary planning and public health recommendations.",[126],"Glycemic Index and Glycemic Load",[128,129,130],"Glycemic index","posprandial glucose response","glycemic load","2025-06-03",{"date":64,"type":36},{"date":68,"type":21},{"date":70,"type":21},{"name":42,"class":43},{"id":137,"slug":138,"hasResults":11,"nctId":139,"briefTitle":140,"officialTitle":140,"acronym":4,"eligibilityCriteria":141,"healthyVolunteers":16,"sex":17,"minAge":52,"maxAge":53,"enrollmentInfo":142,"targetDuration":4,"studyType":22,"phases":143,"briefSummary":144,"conditions":145,"keywords":147,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":131,"lastUpdatePostDateStruct":149,"startDateStruct":150,"completionDateStruct":151,"leadSponsor":152,"locationsCount":44},"100594157","open--labelcross-over-trail-evaluating-the-glycemic-impact-of-peach-varieties-in-healthy-adullts-100594157","NCT07015788","Open -Label,Cross Over Trail Evaluating the Glycemic Impact of Peach Varieties in Healthy Adullts","Inclusion Criteria:• Healthy male and female adults aged 18-50 years\n\n* BMI between 18.5-24.9 kg\u002Fm²\n* Normal fasting blood glucose (\\\u003C100 mg\u002FdL)\n* Willingness to adhere to the study protocol Exclusion Criteria:• Diagnosed diabetes, metabolic syndrome, or any glucose metabolism disorder\n* Use of medications or supplements that affect glucose levels\n* Allergy to peaches or intolerance to test\u002Freference foods\n* Pregnant or breastfeeding women\n* Smoking or use of recreational drugs",{"count":55,"type":21},[57],"This study aims to evaluate the effect of different peach varieties on the glycemic index (GI) in healthy adult participants. While peaches are generally classified as low-GI fruits, variations in sugar composition, fiber content, and ripeness among different cultivars may influence their glycemic response. By assessing and comparing the GI values of several commonly consumed peach varieties, this trial seeks to provide more precise dietary recommendations for glycemic control and support better fruit selection for individuals managing blood glucose levels.",[146],"Blood Glucoe",[148,130],"glycemic index",{"date":64,"type":36},{"date":68,"type":21},{"date":70,"type":21},{"name":42,"class":43},{"id":154,"slug":155,"hasResults":11,"nctId":156,"briefTitle":157,"officialTitle":157,"acronym":4,"eligibilityCriteria":158,"healthyVolunteers":16,"sex":17,"minAge":52,"maxAge":79,"enrollmentInfo":159,"targetDuration":4,"studyType":22,"phases":160,"briefSummary":161,"conditions":162,"keywords":163,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":131,"lastUpdatePostDateStruct":164,"startDateStruct":165,"completionDateStruct":166,"leadSponsor":167,"locationsCount":44},"100594159","comparative-evaluation-of-glycemic-index-of-different-types-of-jaggery-produced-locally-in-pakistan-100594159","NCT07015814","Comparative Evaluation of Glycemic Index of Different Types of Jaggery Produced Locally in Pakistan","Inclusion Criteria:Participants should be clinically healthy, as determined by their medical records and verbal history. Only individuals with normal fasting blood glucose levels (70-99 mg\u002FdL) during screening will be eligible -\n\nExclusion Criteria:1) Participants must not have any chronic disease, not be taking any medications that influence carbohydrate metabolism (such as corticosteroids or metformin), and should be non-smokers and non-alcoholics.\n\n2\\) Pregnant or lactating female participants, as well as any person with gastrointestinal, metabolic, or endocrine disease (e.g., thyroid disease, PCOS, IBD), will be excluded.\n\n3\\) Also, subjects with a history of recent acute illness (within the last 2 weeks) will be deferred.\n\n\\-",{"count":81,"type":21},[57],"This study aims to evaluate and compare the glycemic index (GI) of various types of jaggery by measuring their effect on blood glucose levels in healthy individuals. Using glucose as the reference standard , the objective is to determine how different jaggery types influence postprandial blood sugar response.",[126],[148],{"date":64,"type":36},{"date":68,"type":21},{"date":70,"type":21},{"name":42,"class":43},""]